Research Grants Awarded

Reseach grants support Minnesota scientific and medical research that has the potential to translate to clinical advances in regenerative medicine. Grants typically open every September. Learn more about how to apply for a grant by reading our frequently asked questions

 

View research grants awarded by year.
LaTonya Hickson, MD
Diabetic kidney disease (DKD) is the most common cause of kidney failure in the U.S. and has no adequate cure. Mesenchymal stromal cell (MSC)…
2019-2021
Troy C. Lund, MD, PhD
Successful bone marrow transplant is the only way to cure a number of cancers, bone marrow failure syndromes, and other serious blood disease (like…
2018-2020
Joseph Lillegard, MD, Phd
Hereditary Tyrosinemia Type 1 (HT1) is a genetic disorder that can lead to liver and kidney failure, and is fatal without treatment. There is no…
2018-2020
Daniel Garry, MD, PhD
Cardiovascular disease is the most common cause of death in the United States, and many patients need heart transplants to survive. Currently,…
2018-2020
Terrence C. Burns, MD, PhD
The decline of memory and thinking processes seen in aging, neurodegenerative diseases (like Alzheimer’s disease), and exposure of the brain to…
2018-2020
Raghavendra Rao, MD
Each year in the United States, 12,000 extremely preterm infants (birth before 28 weeks of pregnancy) develop bleeding within the brain soon after…
2018-2020
Robert Tranquillo, PhD
Millions of U.S. citizens suffer from vein valve insufficiency, often resulting in chronic leg ulcers that cause pain, immobility, and a reduced…
2018-2020
Marija Cvetanovic, PhD
Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease with no available therapies. This proposal will determine therapeutic…
2018-2020
Alexander Revzin, PhD
The goal of this project is to develop microcapsules that could be used as cell carriers during differentiation of stem cells into pancreatic…
2018-2020
Ping Chen, PhD
The major challenge in treating obesity is not just losing weight, but preventing weight from coming back. This proposal examines a new treatment…
2018-2019
Mohamad Bydon, MD
This clinical trial investigates whether adipose-derived (fat tissue-derived) mesenchymal stem cells can be safely administered into the…
2018-2020
Nobuaki J. Kikyo, MD, PhD
Many regenerative therapies are based on using a patient’s own cells to create induced pluripotent stem (iPS) cells that can then be differentiated…
2018-2020